Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Quote by Warren Buffet
View:
Post by winr88 on Mar 06, 2023 1:14pm

Quote by Warren Buffet

The stock market is a device for transferring money from the impatient to the patient”


If you own TLT DO NOT SELL.

My opinion is a JV is coming soon. If not a financing after some great news.
Comment by ScienceFirst on Mar 06, 2023 2:12pm
For those that are familiar with such process from the industry, negociations for a jv will take few months and that's the reasons why TLT management mentioned: "plan to iniatiate discussion in 2023/2024 with large pharmaceutical companies for the NMIBC treatment". So those that think a jv is imminent are in for a deception as such process involves the following steps ...more  
Comment by patience69 on Mar 06, 2023 2:50pm
Science no doubt this is a long drawn out process. Do we know for a fact though that it has not begun. Certainly if they are talking to someone no matter how in depth those conversations & info exchange are we are not privy to them. I imagine we will only hear when it is a done deal. Is that correct?
Comment by ScienceFirst on Mar 06, 2023 4:07pm
Patience69 ... You are correct to say that we should not hear about potential negociations as big pharmas will require discretion, like in any negociations.  Big boys like to keep their cards close to their chest.  One day, there will probably have some sorts of rumors, but there's no guarantees on that front.  Of course, any hostile takeover would force TLT Board to go out ...more  
Comment by Rumpl3StiltSkin on Mar 06, 2023 3:14pm
Ok, I agree. A JV or buyout right away is unlikely. But I'd be shocked if we don't get the BTD fairly soon. And AA later this year. So by next year. Mid year we should have something like a JV/buyout in hand. IMO
Comment by StevenBirch on Mar 06, 2023 3:31pm
I agree Rump and if there is a PP happening it's just them being prudent. Adding a few shares to the total means nothing in the long run. It's basically keeping an eye open for any news releases and shutting out the noise.
Comment by Rumpl3StiltSkin on Mar 06, 2023 3:34pm
IF there is a PP right now? It is probably because TLT is spending the money as promised, on keeping this study 2 going full on, plus GLP and maybe some lab work supporting other Phase 1s. All of this stuff takes $$$$$
Comment by Gooseybear on Mar 06, 2023 2:36pm
Drinking more kool aid. Bought 10k more shares just now. This is going to explode one day. Hopefully I can survive bladder cancer long enough to see it.
Comment by CAinPlap on Mar 06, 2023 3:47pm
Glad I dragged my but on funding kids TFSA to buy shares. Am going to wait until the PP is announced to the public as I'm sure the big fish got their phone calls and are responsible for the recent selling. 
Comment by N0taP00p on Mar 06, 2023 4:24pm
As of now, there is no additional info that guarantees this raise will be at a better price than the last time, where they struggled to raise any money for a month and then closed it with a paltry amount bought by insiders.  Why would investors buy anything this time without a material update first?   If the BTD is imminent, wouldn't you as the CEO wait till that happens before ...more  
Comment by skys1 on Mar 06, 2023 5:13pm
As usual, the POOP shows up to trash the company with more phony info. The insiders purchase of the PP was not a "paltry amount". The amount purchased was the required amount determined by the Exchange for that type of "private placement'. The amount was 25% of the total offering. Which is exactly what the did. Next time you show up to trash the company, make sure you have your ...more  
Comment by N0taP00p on Mar 06, 2023 5:18pm
You probably missed the point that no one else bought in.  Was it only for insiders based on what you're saying? Please clarify. 
Comment by skys1 on Mar 06, 2023 5:22pm
You are completely wrong that, "no one else bought in". I don't clarify anything for professional bashers. Go check it out with the Exchange.
Comment by N0taP00p on Mar 06, 2023 5:46pm
As expected. Here's what was offered on October 3rd '22, with closing expected Oct 14th: Under the terms of the Financing, up to 10,000,000 Units are available to be sold to accredited investors at a price of $0.25 per Unit for aggregate gross proceeds of up to $CAN 2,500,000. Here's what was closed on Nov 16th: On closing, the Corporation issued an aggregate of 1,000,000 Units at a ...more  
Comment by DJDawg on Mar 06, 2023 5:49pm
I think that the point was that they did an initial PP which was fully subscribed. They then must have felt that there was enough interest to do a FOLLOW ON PP which was not that well subscribed. Probably because it was only available to "accredited investors". That is not a huge pool. My opinion is that the evidence from the follow on should have told them that, without publicity ...more  
Comment by Kingpin68 on Mar 06, 2023 5:56pm
Exactly Dawg.  And Poop poster has commented on financing concerns over a dozen times since joining the board. Talk about regurgitation.
Comment by N0taP00p on Mar 06, 2023 6:01pm
Thank you DjDawg. That's why we're all hoping a "material"  news release happens before the next raise (assuming it's needed and coming based on our assumptions about the volume jump and price decline today). Hope that's just flippers like you said.  End of the day, we are all eagerly awaiting some good updates. 
Comment by plantrader on Mar 06, 2023 5:33pm
It seems 'the market' isn't going to assign this company credibility until the the FDA does it for them officially first. Can't say I'm too surprised. It's a common dilemma with small companies I think. They may have used up all their mulligans in the past at this point. We also might not know until mid/late June if the company met their 1Q 2023 self-imposed BTD application ...more  
Comment by Eoganacht on Mar 06, 2023 5:55pm
If the company applies in March they should know the result in May. 22. What are the timelines for FDA to respond to a breakthrough therapy designation request?  FDA will respond to breakthrough therapy designation requests within 60 days of receipt of the request. 
Comment by DJDawg on Mar 06, 2023 6:11pm
Given my read on the poster data, they would have been smartest to have submitted once they hit 34 patients at 450 days which would have been in mid or End Feb. The reason I think 34 is smart is that they could have presented the total data set AND commented on the set with the ones that never got a chance to be retreated from the low dose 12. That would be 34 total and Something like 25-28 ...more  
Comment by consultant99 on Mar 06, 2023 6:47pm
There was no need to wait until they got 34 patients treated. The company was very specific in the conditions that needed to be met to achieve BTD as laid out years ago and reinterated ever since.They needed 20-25 patients with a CR rate of at least 20% at 450 days. That was achieved at the end of August 2022. The question that continues to baffle me is if getting BTD is a binary event and if ...more  
Comment by Paradise818 on Mar 06, 2023 7:42pm
As I metioned before, the FDA is corrupt to the bone.  I wouldn't be suprise if they did move the goal post. I'm beginning to believe that they don't want any treatment that is safe and effective (sounds familiar?) to be on the market to compete with Big Pharma.  Theralase drugs are probably are the most effective drugs to come out in decades and TLD-1466 haven't been ...more  
Comment by Eoganacht on Mar 06, 2023 9:46pm
That makes a lot of sense DJDawg. It would be great to be able to present the FDA with the 450 day results of 25 optimized patients so they can get a more accurate read on the true efficacy of the treatment. 
Comment by CAinPlap on Mar 06, 2023 10:25pm
I would like to have data at 450 days for 25 patients post undertreated 12 so 37 total. That way the FDA will have data on 25 that followed the actual protocol of the trial. I suspect that may be what they have been advised to do in their consultations with the FDA. 
Comment by CancerSlayer on Mar 07, 2023 12:48am
  Imo, the end result of the underdosed 12 has nothing to do with their data results & more to do with shortening the timeframe to that "25 patient" threshold. When considering the first 25+ patients treated (non-optimized & optimized), the overall CR% is ultimately sufficient to qualify us for a BTD imo.   If the above is the case, however, the FDA would need to be ...more  
Comment by BlueFranky on Mar 07, 2023 1:16am
Thank you CancerSlayer - your post gave me considerable peace of mind at a time when all of us are clambering for a modicum of clarity, and transparency.
Comment by CancerSlayer on Mar 07, 2023 1:21am
  Re: a decision for an accelerated approval, data soundness is even more applicable & such a decision is based on a smaller subset of patients.... the first 12 treated should in no way be considered in that determination.   If the optimized data continue to trend favorably, I don't believe such a determination would pose any significant delays, especially if you were to ...more  
Comment by plantrader on Mar 06, 2023 6:49pm
Thanks for that catch Eog. I knew it was 60 days but somehow I typed June by mistake.
Comment by Eoganacht on Mar 06, 2023 9:32pm
No problem plantrader. It's even possible Theralase submitted the application in January, in which case we could get BTD this month!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250